Personality vulnerabilities and adverse event reporting in phase 1 clinical studies

Authors: Joanna Skommer, Krish Gunesh, Thomas M. Polasek

Source: Trials, Vol 25, Iss 1, Pp 1-4 (2024)

Subject Terms: Phase 1 clinical trials, Healthy volunteers, Personality, Medicine (General), R5-920

File Description: electronic resource

Relation: https://doaj.org/toc/1745-6215

Access URL: https://doaj.org/article/4581233f44644036845d84289a9e73a9

The Requirements of Managing Phase I Clinical Trials Risks: The British and Italian Case Studies

Authors: Davide Di Tonno, Laura Martena, Manuela Taurisano, Caterina Perlin, Anna Chiara Loiacono, Stefano Lagravinese, Santo Marsigliante, Michele Maffia, Susanna Esposito, Gianluca Villa, Giovanni Gori, Leonardo Bray, Alessandro Distante, Alessandro Miani, Prisco Piscitelli, Alberto Argentiero

Source: Epidemiologia, Vol 5, Iss 1, Pp 137-145 (2024)

Subject Terms: Phase 1 Clinical Trials, risk management, European Regulation, new drug development, UK, Italy, Internal medicine, RC31-1245

File Description: electronic resource

Relation: https://www.mdpi.com/2673-3986/5/1/9; https://doaj.org/toc/2673-3986

Access URL: https://doaj.org/article/9da6f301bfea405781f2a6adfefbe736

A review of clinical trials registered in India from 2008 to 2022 to describe the first-in-human trials

Authors: Sowparnika Treasa Sabu, Shravan Venkatraman, Jerin Jose Cherian, Saibal Das, Monika Pahuja, Tulsi Adhikari, Shoibal Mukherjee, Nabendu Sekhar Chatterjee, Nilima Arun Kshirsagar

Source: Perspectives in Clinical Research, Vol 15, Iss 1, Pp 18-23 (2024)

Subject Terms: clinical trials registry – india, indian council of medical research, investigational new drugs, phase 1 clinical trials, Medicine, Medicine (General), R5-920

File Description: electronic resource

Relation: http://www.picronline.org/article.asp?issn=2229-3485;year=2024;volume=15;issue=1;spage=18;epage=23;aulast=; https://doaj.org/toc/2229-3485

Access URL: https://doaj.org/article/0d2ff87766014d209db47647c0e5b383

Phase Ib study of combinations of avadomide (CC‐122), CC‐223, CC‐292, and rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma

Authors: Vincent Ribrag, Julio C. Chavez, Carola Boccomini, Jason Kaplan, Jason C. Chandler, Armando Santoro, Paolo Corradini, Ian W. Flinn, Ranjana Advani, Philippe A. Cassier, Randeep Sangha, Vaishalee P. Kenkre, Iris Isufi, Shailaja Uttamsingh, Patrick R. Hagner, Anita K. Gandhi, Frank Shen, Sophie Michelliza, Harald Haeske, Kristen Hege, Michael Pourdehnad, John Kuruvilla

Source: eJHaem, Vol 3, Iss 1, Pp 139-153 (2022)

Subject Terms: new drug development, non‐Hodgkin lymphoma, phase 1 clinical trials, Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: https://doaj.org/toc/2688-6146

Access URL: https://doaj.org/article/96c484da7911405ebd05aa9e00d581f2

Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration

Authors: Sungyeun Bae, Ki Young Huh, Jaeseong Oh, Kyung-Sang Yu, Anhye Kim

Source: Pharmaceuticals, Vol 16, Iss 1, p 132 (2023)

Subject Terms: dry eye syndrome, Sjogren syndrome, phase 1 clinical trials, bioavailability, Medicine, Pharmacy and materia medica, RS1-441

File Description: electronic resource

Relation: https://www.mdpi.com/1424-8247/16/1/132; https://doaj.org/toc/1424-8247

Access URL: https://doaj.org/article/d74fa676dd614b29916a804873000fdd

Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy

Authors: Mehmet Asim Bilen, Julie M. Shabto, Dylan J. Martini, Yuan Liu, Colleen Lewis, Hannah Collins, Mehmet Akce, Haydn Kissick, Bradley C. Carthon, Walid L. Shaib, Olatunji B. Alese, Conor E. Steuer, Christina Wu, David H. Lawson, Ragini Kudchadkar, Viraj A. Master, Bassel El-Rayes, Suresh S. Ramalingam, Taofeek K. Owonikoko, R. Donald Harvey

Source: BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)

Subject Terms: Immunotherapy, Phase 1 clinical trials, Sites of metastasis, Liver metastasis, Clinical outcomes, Tumor immunology, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s12885-019-6073-7; https://doaj.org/toc/1471-2407

Access URL: https://doaj.org/article/3a89538b1b6f4594bd638b17c5ad5f05

Phase I study evaluating the safety, tolerability and pharmacokinetics of a novel oral dissolvable film containing dexamethasone versus Fortecortin dexamethasone tablets

Authors: Zuzana Diamant, Gabriella Samuelsson Palmgren, Bengt Westrin, Leif Bjermer

Source: European Clinical Respiratory Journal, Vol 4, Iss 1 (2017)

Subject Terms: dexamethasone, drug formulation, phase 1 clinical trials, pharmacokinetics, allergy, anaphylaxis, Diseases of the respiratory system, RC705-779

File Description: electronic resource

Relation: https://doaj.org/toc/2001-8525

Access URL: https://doaj.org/article/ab620b817ddd4cffa336c288fe253b6a

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.